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Abstract
Objectives: To evaluate the strength of association be-
tween maternal and pregnancy characteristics and the risk
of adverse perinatal outcomes in pregnancies with labo-
ratory confirmed COVID-19.
Methods: Secondary analysis of a multinational, cohort
study on all consecutive pregnant women with laboratory-
confirmed COVID-19 from February 1, 2020 to April 30,
2020 from 73 centers from 22 different countries. A
confirmed case of COVID-19 was defined as a positive
result on real-time reverse-transcriptase-polymerase-
chain-reaction (RT-PCR) assay of nasal and pharyngeal
swab specimens. The primary outcome was a composite
adverse fetal outcome, defined as the presence of either
abortion (pregnancy loss before 22 weeks of gestations),
stillbirth (intrauterine fetal death after 22 weeks of
gestation), neonatal death (death of a live-born infant
within the first 28 days of life), and perinatal death (either
stillbirth or neonatal death). Logistic regression analysis
was performed to evaluate parameters independently
associated with the primary outcome. Logistic regression
was reported as odds ratio (OR) with 95% confidence in-
terval (CI).
Results: Mean gestational age at diagnosis was
30.6±9.5 weeks, with 8.0% of women being diagnosed in
the first, 22.2% in the second and 69.8% in the third
trimester of pregnancy. There were six miscarriage (2.3%),
six intrauterine device (IUD) (2.3) and 5 (2.0%) neonatal
deaths, with an overall rate of perinatal death of 4.2% (11/
265), thus resulting into 17 cases experiencing and 226 not
experiencing composite adverse fetal outcome. Neither
stillbirths nor neonatal deaths had congenital anomalies
found at antenatal or postnatal evaluation. Furthermore,
none of the cases experiencing IUD had signs of impending
demise at arterial or venous Doppler. Neonatal deaths were
all considered as prematurity-related adverse events. Of
the 250 live-born neonates, one (0.4%) was found positive
at RT-PCR pharyngeal swabs performed after delivery. The
mother was tested positive during the third trimester of
pregnancy. The newborn was asymptomatic and had
negative RT-PCR test after 14 days of life. At logistic
regression analysis, gestational age at diagnosis (OR: 0.85,
95% CI 0.8–0.9 per week increase; p<0.001), birthweight
(OR: 1.17, 95% CI 1.09–1.12.7 per 100 g decrease; p=0.012)
andmaternal ventilatory support, including either need for
oxygen or CPAP (OR: 4.12, 95% CI 2.3–7.9; p=0.001) were
independently associated with composite adverse fetal
outcome.
Conclusions: Early gestational age at infection, maternal
ventilatory supports and low birthweight are the main
determinants of adverse perinatal outcomes in fetuses with
maternal COVID-19 infection. Conversely, the risk of ver-
tical transmission seems negligible.
Keywords: Coronavirus; perinatal mortality; perinatal
morbidity.
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Introduction
Towards the end of 2019, a novel Coronavirus mutation -
labelled as Severe Acute Respiratory Syndrome Coronavi-
rus 2 (SARS-COV-2) - was identified as the cause of a
respiratory illness called COVID-19, that suddenly became
epidemic in China, and then dramatically spread in many
other countries worldwide as a global pandemic [1–9].
Despite rigorous mitigation measures adopted by govern-
ments to reduceboth thevirus spreadand itsdetrimental effects
on healthcare systems and therefore on the whole worldwide
economy [10], COVID-19 has currently affected about five mil-
lions of people with more than 300,000 deaths [11].
Although evidence is accumulating rapidly, there are
still several outstanding issues that need to be settled soon
regarding the effect of COVID-19 on perinatal outcomes to
guide the antenatal counselling and management of
women with COVID-19 during pregnancy.
In a largemultinational cohort study, we have recently
shown that COVID-19 in pregnant women is associated
with low rate of maternal mortality, but 11.1% rate of
admission to intensive care unit (ICU) [12].
However, an accurate risk stratification of womenwith
COVID-19 is needed to ascertain the association between
different maternal characteristics or clinical findings and
adverse perinatal outcomes, in order tomore appropriately
tailor their management.
The primary aim of this study was to report perinatal
outcome in pregnancies complicated by COVID-19 infection;
the secondary aim was to elucidate the strength of associ-
ation between maternal and pregnancy characteristics and
the risk of adverse perinatal outcome in these pregnancies.
Materials and methods
Study design and participants
This is a secondary analysis of the World Association of Perinatal
Medicine (WAPM) study [12]. The WAPM study was a multinational,
cohort study on all consecutive pregnant women with laboratory-
confirmed COVID-19 from February 1, 2020 to April 30, 2020 from 73
centers from 22 different countries (Argentina, Australia, Belgium,
Brazil, Colombia, Czech Republic, Finland, Germany, Greece, Israel,
Italy, NorthMacedonia, Peru, Portugal, Republic of Kosovo, Romania,
Russia, Serbia, Slovenia, Spain, Turkey, and United States)
COVID-19 was diagnosed on the basis of The World Health Or-
ganization (WHO) interimguidance [13]. A confirmed case of COVID-19
was defined as a positive result on real-time reverse-transcriptase-
polymerase-chain-reaction (RT-PCR) assay of nasal and pharyngeal
swab specimens [14, 15].
The study was approved by the IRB of the University of Naples
Federico II (April 2020, approval number: 145/2020).
A composite adverse fetal outcome was defined as the presence
of either:
– Abortion, defined as pregnancy loss before 22 weeks of
gestations,
– Stillbirth, defined as intrauterine fetal death after 22 weeks of
gestation,
– Neonatal death, defined as death of a live-born infant within the
first 28 days of life,
– Perinatal death, defined as either stillbirth or neonatal death.
Statistical analysis
Statistical analysis was performed using Statistical Package for Social
Sciences (SPSS) v. 19.0 (IBM Inc., Armonk, NY, USA). Continuous
variables were reported as means ± standard deviation (SD), while
categorical as numbers (percentage). Univariate comparisons of
dichotomous data were performed with the use of the χ2-test with
continuity correction. Comparisons between groups were performed
with the use of the T-test to test group means by assuming equal
within-group variances for parametric data, and with the use of Wil-
coxon and Mann-Whitney tests for nonparametric data. We also
planned to test the strength of association between different maternal
and pregnancy characteristics, and clinical, radiological, and labo-
ratory findings, with a composite adverse fetal outcome. Logistic
regression analysis was also performed to evaluate parameters inde-
pendently associatedwith a composite adverse fetal outcome. Logistic
regression was reported as odds ratio (OR) with 95% confidence in-
terval (CI). For the purpose of the analysis, this analysiswas performed
including only women with completed pregnancy. A p-value <0.05
was considered statistically significant.
Results
The WAPM study involved 388 singleton pregnancies
positive to COVID-19 at RT-PCR nasal and pharyngeal
swab, in 73 centers from 22 different countries.
Mean gestational age at diagnosis was 30.6±9.5 weeks,
with 8.0% of women being diagnosed in the first, 22.2% in
the second and 69.8% in the third trimester of pregnancy.
Included women were asymptomatic in 24.2% of cases. The
most common symptom at the time of triage was cough
(52.1%), followedby fever (44.1%),while shortness of breath
was complainedby60women (15.5%). 11.1%ofwomenwere
admitted to ICU, and 6.4% requiring intubation. There were
three cases of maternal deaths, accounting for a maternal
mortality rate of 0.8% [12].
Evaluation of the potential risk factors associated with
the occurrence of the composite adverse fetal outcomewas
performed only in women with completed pregnancy.
Table 1 shows perinatal outcomes from the WAPM
study. There were six miscarriage (2.3%), six intrauterine
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device (IUD) (2.3) and 5 (2.0%) neonatal deaths, with an
overall rate of perinatal death of 4.2% (11/265), thus
resulting into 17 cases experiencing and 248 not experi-
encing composite adverse fetal outcome. Neither stillbirths
nor neonatal deaths had congenital anomalies found at
antenatal or postnatal evaluation. Furthermore, none of
the cases experiencing IUD had signs of impending demise
at arterial or venous Doppler (reverse end diastolic flow in
the umbilical artery, increased ductus venosus pulsatility
index, absent or reverse a wave in the ductus venosus).
Neonatal deathswere all considered as prematurity-related
adverse events. Of the 250 live-born neonates, one (0.4%)
was found positive at RT-PCR pharyngeal swabs performed
after delivery. The mother was tested positive during the
third trimester of pregnancy. The newborn was asymp-
tomatic and had negative RT-PCR test after 14 days of life.
Unfortunately, amniotic fluid was not tested, and speci-
mens from placenta were not obtained, thus questioning
whether the infection occurred in utero (antenatal vertical
transmission) or after immediately prior or after birth
(perinatal vertical transmission).
When exploring maternal and pregnancy charac-
teristics, gestational age at diagnosis was lower
(23.2±10.9 vs. 35.0±4.6, p<0.001) in fetuses with com-
posite adverse outcome, while there was no difference in
maternal age at the infection between the two study
groups. Similarly, the incidence of composite adverse
fetal outcome was significantly higher when the infec-
tion occurred in the first trimester (35.3 vs. 2%, p<0.001).
The incidence of composite adverse fetal outcome was
significantly higher in fetuses with lower birthweight
(2007±1014 g vs. 2939±755, p<0.001), while it was similar
in nulliparous women, women smoking during preg-
nancy or with chronic, pre-existing conditions, women
undergone flu vaccination, and those with a positive CT
scan.
When focusing on clinical, radiological and labo-
ratory findings, maternal need for oxygen (41.2 vs.
17.3%, p=0.02) and CPAP (29.4 vs. 8.5%, p=0.02) were
significantly associated with composite adverse fetal
outcome
Finally, no difference was found when evaluating the
effect different pharmacologic treatments (LMWH, azi-
thromycin, antiviral drugs or hydroxychloroquine) on
composite adverse fetal outcome
At logistic regression analysis, gestational age at
diagnosis (OR: 0.85, 95% CI 0.8–0.9 per week increase;
p<0.001), birthweight (OR: 1.17, 95% CI 1.09–1.12.7 per
100 g decrease; p=0.012) andmaternal ventilatory support,
including either need for oxygen or CPAP (OR: 4.12, 95% CI
2.3–7.9; p=0.001) were independently associated with
composite adverse fetal outcome.
Discussion
Summary of the main findings
The findings from this study showed that, in pregnancies
complicated by COVID-19 infection, the rate of perinatal
death was about 4%, mainly related to prematurity. Early
gestational age at diagnosis, gestational age at diagnosis,
birthweight and maternal ventilatory support were the
only factors independently associated with adverse fetal
outcome. Finally, the risk of vertical transmission was
negligible.
Strengths and limitations
To our knowledge, this may be the largest cohort of COVID-
19 during pregnancy published so far. Strengths and limi-
tations of this secondary analysis are those inherent in the
WAPM study. The enrollment of only of women with
laboratory-confirmed COVID-19 and the inclusion of both
University Hospitals and Community Hospitals from
Table : Perinatal outcomes from the WAPM study [].
Women with completed pregnancies (n=) % (% CI)
Elective termination of pregnancy  . (.–.)
Stillbirth  . (.–.)
Perinatal death  . (.–.)
IUGR  . (.–.)
Preterm birth  . (.–.)
Live-born infants  . (.–.)
Women with live-born infants (n=) % (% CI)
Possible vertical transmission  . (.–.)
Neonatal deatha  . (.–.)
Admission to NICU  . (.–.)
Breastfeeding  . (.–.)
Skin to skin  . (.–.)
Low birth weight  . (.–.)




Gestational age at delivery,
years, mean ± SD
. ± .
Birth weight, grams, mean ± SD  ± 
Data are presented as number (percentage) or as mean ± standard
deviation (SD). NICU, neonatal intensive care unit; LBW, low birth
weight; IUGR, intrauterine growth restriction. aIncluding only live-born
infants. bIncluding only women with first trimester infection.
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different countries represent the major strengths of this
study. The major limitation of the study is the incidence of
the composite adverse perinatal outcome in the overall
population is low, thus making our sample size potentially
underpowered to drawn any convincing evidence. Another
limitation is the inclusion of only high-income andmiddle-
income countries, and therefore we acknowledge that in
low-income countries perinatal outcomes might be even
worse [3].
Implications for clinical practice and
research
COVID-19 has brought the scientific community into un-
precedented times and currently represents the major
global public health issue. Despite the growing number of
reports published so far [16–18], evidence is still limited
particularly when focusing on vulnerable conditions, such
as pregnancy.
We have recently shown that COVID-19 in pregnant
women is associated with low rate of maternal mortality, but
11.1% rate of admission to ICU. Furthermore, earlier gesta-
tional age at presentation, shortness of breath as presenting
symptom, and increased lactate dehydrogenase (LDH) levels
were independently associated with composite adverse
maternal outcome including either admission to intensive
care unit, use of mechanical ventilation or death [12].
In this secondary analysis, we planned to ascertain
whether different maternal and pregnancy characteristics;
clinical, laboratory or radiological findings and pharma-
cological treatments could be associated with serious
adverse perinatal outcomes, including stillbirths and
neonatal deaths, and we found that earlier gestational age
at diagnosis, birthweight andmaternal ventilatory support
were independently associated with a composite adverse
perinatal outcome.
Gestational age at diagnosis is a peculiar issue when
assessing pregnancies affected by viral infections and the
occurrence of the infection earlier in pregnancy is usually
associated with worse fetal outcomes. In a large meta-
analysis of cohort and case-control studies, maternal sea-
sonal influenza or influenza-like illness in the first trimester
was associated with a significantly higher risk of congenital
abnormalities, such as cleft lip, neural tube defects, hy-
drocephaly, and congenital heart defects [19]. Moreover,
recent data on women with a primary Cytomegalovirus
infection andan infected child agedat least 1 year at the time
of the analysis show that the infection can be severe only
when the virus hits the fetus in the embryonic or early fetal
period [20]. Alongside the high burden of fetal morbidity,
parvovirus B19 infection in the first trimester of pregnancy
was associated with an increased risk of fetal loss [21] and
fetal death is generally observed when the infection occurs
before the completed 20 weeks of gestation [22].
These data are concordant with our results, as COVID-
19 infection in the first trimester was significantly associ-
ated with the occurrence of a composite adverse fetal
outcome, while there was no difference when the infection
occurred during the second and the third trimester of
pregnancy.
Therefore, longitudinal evaluation of pregnancies
affected with COVID-19 is recommended to rule out any
potential factor that may significantly impact short and
long‐term prognosis. In this scenario, the use of neuro-
sonography and fetal magnetic resonance imaging (MRI),
that has significantly spread in the past few years in several
fields of maternal fetal medicine [23, 24], might be judi-
ciously considered as useful imaging techniques for a
complete fetal assessment.
Perinatal death is certainly one of the main concern of
maternal fetal specialists. So far, the rate of both stillbirths
and neonatal deaths has been reported to be slightly
increased, although the majority of neonatal deaths are
considered to be related to prematurity or to critically ill
mothers [3, 25, 26].
COVID-19 may predispose the general population to a
thrombotic condition, both in the venous and arterial cir-
culations, due to inflammation, platelet activation, endo-
thelial dysfunction, and stasis [27, 28]. This COVID-19
related hypercoagulability state might intuitively assume
an important role in pregnancy due to its inherent pro-
thrombotic state, and might represent a possible cause of
the small increase of the rate of stillbirths compared with
the baseline population [29–32].
However, we acknowledge that the sample size
potentially underpowered for this outcome and the
lack of effect of low molecular weight heparin cast some
doubt on this hypothesis and do not allow to obtain robust
evidence on the risk of stillbirth in pregnancies affected
by COVID-19.
Conclusions
Early gestational age at infection, maternal ventilatory
supports and low birthweight are themain determinants of
adverse perinatal outcomes in fetuses with maternal
COVID-19 infection. Conversely, the risk of vertical trans-
mission seems negligible.
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